CognitOss Granted FDA Breakthrough Device Designation

Locate Bio was granted Breakthrough Device designation from FDA for CognitOss, bone graft developed to treat chronic osteomyelitis.

CognitOss presents an alternative to surgical debridement, long-term, high-dose administration of antibiotics, and bone grafting which often requires a second surgical procedure to remove the non-resorbable...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us